| News

Investments in Basel start-ups on the rise

21.10.2019

Start-ups established in Basel raised more than 200 million euro in investments during the first half of 2019. Basel therefore leads the way in this regard within Switzerland, and stands in eighth place across Europe, as revealed by a new EY study.

Start-up (img: Ken Easter/shutterstock)

The consultancy firm EY has presented its latest Start-up-Barometer Europe. This study analyzes the equity financing of European start-ups. Across Europe, a total of 16.9 billion euro was accordingly invested in start-ups during the first half of 2019. This represents growth of 62 percent in comparison with the same period of last year. This increase was also replicated in Switzerland, and in Basel in particular.

While a total of 592 million euro in investments (H1 2018: 405 million euro) secures fifth place for Switzerland in the country rankings, Basel was ranked among the top ten for the first time, taking eighth place in the process. Following on from a total of 24 million euro in the first half of 2018, the equivalent value for the first six months of the current year stood at 203 million euro. London (5.7 billion euro), Paris (2.2 billion euro) and Berlin (1.9 billion euro) took the top three positions respectively. In Switzerland, two other cities made their way into the top 20: Zurich was ranked in 16th position (117 million euro vs. 160 million euro in the same period of the previous year), while Lausanne (97 million euro) came in 19th place.

One start-up, namely Arvelle Therapeutics, made a particularly great contribution to Basel’s high ranking. No other Swiss start-up raised more money from investment during the first half of 2019 (169 million euro) than the spin-off of the Basel-based Axovant Sciences, which in turn form part of Roivant Sciences. Arvelle specializes in treatments for the central nervous system. Having raised a total of 21 million euro, Polyneuron Pharmaceuticals, which is also based in Basel, took fifth place among Swiss companies.

EY also analyzed the number of financing rounds for its study. Here, Switzerland also came in fifth place with a total of 150 rounds. As was the case in terms of investment volume, Switzerland is behind the UK (537 rounds; 6.6 billion euro), France (387 rounds; 2.8 billion euro), Germany (331 rounds; 2.6 billion euro) and Sweden (163 rounds; 1.3 billion euro). Zurich leads the way among Swiss cities for rounds of financing, taking fifth place (48 rounds) in the European rankings. Here, London again tops the charts with 323 rounds.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.